Wednesday, May 17, 2017

BRIEF-Health Canada approves Bristol-Myers' opdivo(nivolumab)

* Health Canada approves opdivo (nivolumab) for the treatment of squamous cell carcinoma of the head and neck

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)